Loprox and Radiation myelopathy - a phase IV clinical study of FDA data
We study 603 people who take Loprox or have Radiation myelopathy. No report of Radiation myelopathy is found in people who take Loprox.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Loprox?
Loprox has active ingredients of ciclopirox. eHealthMe is studying from 560 Loprox users for its effectiveness, alternative drugs and more.
What is Radiation Myelopathy?
Radiation myelopathy (spinal cord injury due to radiation) is found to be associated with 31 drugs and 25 conditions by eHealthMe.
Do you take Loprox and have Radiation myelopathy?Check whether Radiation myelopathy is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Radiation myelopathy and when was it recovered:
Expand to all the drugs that have ingredients of ciclopirox:
Alternative drugs to, pros and cons of Loprox:
- Loprox (560 reports)
Radiation myelopathy treatments and more:
- Radiation myelopathy (43 reports)
COVID vaccines that are related to Radiation myelopathy:
- Radiation myelopathy in Moderna COVID Vaccine
- Radiation myelopathy in Pfizer BioNTech Covid Vaccine
- Radiation myelopathy in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Radiation myelopathy:
All the conditions that are associated with Radiation myelopathy:
How the study uses the data?
The study uses data from the FDA. It is based on ciclopirox (the active ingredients of Loprox) and Loprox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Visicol and Coronary Heart Disease - 2 seconds ago
- Miralax and Valcyte drug interaction - 2 seconds ago
- Trileptal and Plendil drug interaction - 7 seconds ago
- Ganciclovir Sodium and Normochromic Normocytic Anaemia - 9 seconds ago
- Nitrostat and Anorexia - 10 seconds ago
- Diamox and Diplopia - 15 seconds ago
- Accuretic and Thyroxine Free Increased - 15 seconds ago
- Pancuronium Bromide and Multi-Organ Failure - 18 seconds ago
- Imodium and Dermatitis Contact - 24 seconds ago
- Hydroxyurea and Basaglar drug interaction - 36 seconds ago